Moore Capital Management’s Avanos Medical AVNS Stock Holding History

Moore Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-97,960	Closed	-$1.37M	–	751
2026 Q1	$1.37M	Sell	97,960 -3,925	-4%	-$52.9K	0.03%	340
2025 Q4	$1.14M	Buy	101,885 +13,626	+15%	+$156K	0.02%	438
2025 Q3	$1.02M	Buy	88,259 +34,812	+65%	+$408K	0.01%	424
2025 Q2	$654K	Sell	53,447 -7,840	-13%	-$98.6K	0.01%	411
2025 Q1	$878K	Buy	61,287 +24,217	+65%	+$378K	0.02%	327
2024 Q4	$590K	Buy	+37,070	New	+$734K	0.01%	412

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Moore Capital Management's AVNS Position: Q2 2026 in Review

Moore Capital Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 97,960 shares — an estimated $1.37M sold.

Moore Capital Management first reported a position in AVNS in Q4 2024 and held it in 6 quarters. The position peaked at $1.37M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Moore Capital Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
Moore Capital Management sold 97,960 Avanos Medical shares in Q2 2026, an estimated $1.37M.
Moore Capital Management first reported a position in Avanos Medical in Q4 2024 and held it in 6 quarters.
Moore Capital Management's Avanos Medical position peaked at $1.37M in Q1 2026.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.